Laura Beauregard

Milestone for Women’s HIV Prevention EMA Adopts Positive Opinion on IPM’s Dapivirine Ring to Reduce HIV Risk

2020/07/29: In a milestone for women’s HIV Prevention, the European Medicines Agency (EMA) adopted a positive opinion on the International Partnership for Microbicides (IPM) Dapivirine Vaginal Ring to reduce HIV risk.DF/Net Research welcomes this EMA action which moves a much-needed, woman-initiated HIV prevention option one step closer to reaching women who urgently need it.The monthly […]

Milestone for Women’s HIV Prevention EMA Adopts Positive Opinion on IPM’s Dapivirine Ring to Reduce HIV Risk Read More »

DFnet and TCD launch COVID-19 Treatment Trial in South Africa

2020/06/10: The last week of May saw a milestone for the newest study that DF/Net is involved in — the Kickoff Meeting to launch a COVID-19 Treatment Trial in South Africa. DF/Net is partnering with TCD to provide the clinical trial services for this important study, which will be recruiting participants in Johannesburg, South Africa.  The study timeline

DFnet and TCD launch COVID-19 Treatment Trial in South Africa Read More »